obesity drug news - Search News

Amgen, obesity

Newsweek on MSN · 6h

Amgen Obesity Drug More Effective Than Competitors

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

CNBC on MSN · 2d

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other experimental treatments.

BioPharma Dive · 1d

Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark

Shares in Amgen fell by double digits Tuesday on results for the company’s MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound.

Medicaid, Biden and obesity

ABC News on MSN · 1d

Biden administration proposes expanding obesity drug coverage under Medicare and Medicaid

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid.

CNN on MSN · 1d

7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration.

Newsweek on MSN · 23h

Should Medicare, Medicaid Cover Anti-Obesity Drugs? Doctors Speak Out

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

1don MSN

New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

17hon MSN

Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

21h

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Pharmalittle: We’re reading about Trump’s FDA pick, problems with a Merck asthma drug, and more

Martin Makary, President-elect Trump’s pick to run the U.S. Food and Drug Administration ... in the middle of a fight ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results